Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced Apoptosis

International Journal of Biological Sciences

Volumn 10, Issue 5, 2014, Pages 466-478

  Notaro, Antonietta ^a   Sabella, Selenia ^a   Pellerito, Ornella ^b   Di Fiore, Riccardo ^a   De Blasio, Anna ^a   Vento, Renza ^a   Calvaruso, Giuseppe ^a   Giuliano, Michela ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Autophagy; Cannabinoids; ER stress; GRP78 PAR 4 complex; Osteosarcoma cells; TRAIL

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ACRIDINE ORANGE; APOPTOSIS REGULATORY PROTEIN; BENZOXAZINE DERIVATIVE; CADAVERINE; CANNABINOID RECEPTOR AGONIST; DANSYLCADAVERINE; HEAT SHOCK PROTEIN; MAP1LC3A PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MOLECULAR CHAPERONE GRP78; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PROSTATE APOPTOSIS RESPONSE-4 PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANALOGS AND DERIVATIVES; APOPTOSIS; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DRUG EFFECTS; ENDOPLASMIC RETICULUM STRESS; GENETICS; HUMAN; METABOLISM; OSTEOSARCOMA; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ACRIDINE ORANGE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BENZOXAZINES; CADAVERINE; CANNABINOID RECEPTOR AGONISTS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOPLASMIC RETICULUM STRESS; HEAT-SHOCK PROTEINS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MORPHOLINES; NAPHTHALENES; OSTEOSARCOMA; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84899767819     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.8337     Document Type: Article

References (38)

1. Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 2007; 26: 1-18.
2. Bifulco M, Laezza C, Pisanti S, Gazzerro P. Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol. 2006; 148: 123-35.
3. Flygare J, Sander B. The endocannabinoid system in cancer-potential therapeutic target? Semin Cancer Biol. 2008; 18: 176-89.
4. Sarfaraz S, Adhami VM, Syed DN, Afaq F, et al. Cannabinoids for cancer treatment: progress and promise. Cancer Res. 2008; 68: 339-42.
5. Pisanti S, Bifulco M. Endocannabinoid system modulation in cancer biology and therapy. Pharmacol Res. 2009; 60: 107-16.
6. Velasco G, Galve-Roperh I, Sànchez C, et al. Cannabinoids and ceramide: two lipids acting hand-byhand. Life Sci. 2005; 77: 1723-31.
7. Galve-Roperh I, Sànchez C, Cortés ML, et al. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Med. 2000; 6: 313-9.
8. Sarker KP, Biswas KK, Yamakuchi M, et al. ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. J Neurochem. 2003; 85: 50-61.
9. Demuth DG, Molleman A. Cannabinoid signalling. Life Sci. 2006; 78: 549-63.
10. Pozzoli G, Tringali G, Vairano M, et al. Cannabinoid agonist WIN55, 212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bclxL gene expression. J Neurosci Res. 2006; 83: 1058-65.
11. Yang Z, Klionsky DJ. An Overview of the Molecular Mechanism of Autophagy. Curr Top Microbiol Immunol. 2009; 335: 1-32.
12. Levine B. Cell biology: autophagy and cancer. Nature 2007; 446: 745-7.
13. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004; 23: 2891-906.
14. Salazar M, Carracedo A, Salanueva IJ, et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest. 2009; 119: 1359-72.
15. Rubino S, Portanova P, Girasolo A, et al. Synthetic, structural and biochemical studies of polynuclear platinum(II) complexes with heterocyclic ligands. Eur J Med Chem. 2009; 44: 1041-8.
16. Calvaruso G, Giuliano M, Portanova P, et al. G. Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors. Oncol Rep. 2007; 18: 447-50.
17. Cheng CH, Shu KH, Chang HR, Chou MC. Cyclosporine-induced tubular vacuolization: the role of Bip/Grp78. Nephron Exp Nephrol. 2012; 122: 1-12.
18. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. Embo J. 2000; 19: 5720-8.
19. Fujita N, Itoh T, Omori H, et al. The Atg16L Complex Specifies the Site of LC3 Lipidation for Membrane Biogenesis in Autophagy. Mol Biol Cell. 2008; 19: 2092-100.
20. Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy. Semin Immunopathol. 2010; 32: 431-6.
21. Biederbick A, Kern HF, Elsässer HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 1995; 66: 3-14.
22. Paglin S, Hollister T, Delohery T, Hackett N, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001; 61: 439-44.
23. Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 1982; 79: 1889-92.
24. Pellerito O, Calvaruso G, Portanova P, et al. The synthetic cannabinoid WIN 55, 212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis. Mol Pharmacol. 2010; 77: 854-63.
25. Burikhanov RK, Zhao Y, Goswami A, et al. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 2009; 138: 377-88.
26. Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem J. 2011; 434: 181-8.
27. Aki T, Nara A, Uemura K. Cytoplasmic vacuolization during exposure to drugs and other substances. Cell Biol Toxicol. 2012; 28: 125-31.
28. Wasik AM, Almestrand S, Wang X, et al. WIN55, 212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells. Cell Death Dis. 2011; 2: e225.
29. Wang S, El-Deiry WS. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003; 22: 8628-33.
30. Zhang XD, Nguyen T, Thomas WD, et al. Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett. 2000; 482: 193-9.
31. He W, Wang Q, Xu J, Xu X, Padilla MT, Ren G, Gou X, Lin Y. Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2-and RIPK1/RIP1-mediated MAPK8/JNK activation. Autophagy 2012; 8: 1811-21.
32. Jin SM, Jang HW, Sohn SY, Kim NK, Joung JY, Cho YY, Kim SW, Chung JH. Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells. Endocrine 2014; 45: 256-62.
33. Giansanti V, Torriglia A, and Scovassi AI. Conversation between apoptosis and autophagy. "Is it your turn or mine"? Apoptosis 2011; 16: 321-333.
34. Maiuri MC, Zalckvar E, Kimchi A, and Kroemer G. Self-eating and self-killing. Cross-talk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007; 8: 741-52.
35. Young MM, Takahashi Y, Khan O, Park S, Hori T, Yun J, Sharma AK, Amin S, Hu CD, Zhang J, Kester M, Wang HG. Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis. J Biol Chem. 2012; 287: 12455-68.
36. Hebbar N, Wang C, Rangnekar VM. Mechanisms of apoptosis by the tumor suppressor Par-4. J Cell Physiol. 2012; 227: 3715-21.
37. Chakraborty M, Qiu SG, Vasudevan KM, Rangnekar VM. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res. 2001; 61: 7255-63.
38. Lee TJ, Jang JH, Noh HJ, Park EJ, Choi KS, Kwon TK. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells. J Cell Biochem. 2010; 109: 885-95.